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M40401 is a well known antioxidant and as of late, it has been studied for anti-
HIV properties.  It was reported to reduce apoptosis of astrocytes caused by HIV-
1 infected macrophages (M/M) supernatants, and in 2005, a poster presented at 
the International Conference for Antiviral Research claimed that HIV-1 
replication was reduced in infected M/M when treated with M40401.  Our goal is 
to synthesize M40403, a similar molecule, as well as other related molecules for 
further study.  M40403 and previously synthesized related molecules have been 
shown to have anti-HIV properties.  We will synthesize more related molecules in 
an attempt to maximize the ratio of potency to toxicity.  Hopefully by tweaking 
the molecules, we will find one that can eventually be made into a drug to help 




 Heterocycles (derived from hetero 
meaning “other or different” and cycle 
meaning “cyclic molecule”) are a large 
division of organic chemistry defined by 
their ring-like structure that is composed of 
at least two different atoms.  Heterocycles 
are known to be very important in biological 
and industrial applications.  For example, 
penicillin, caffeine, nucleic acids, and many 
types of vitamins are all molecules that 
contain heterocycles.(1) (See Figure 1) 
 
Figure 1: Penicillin 
 Macrocyclic polyamines are a 
specific division of heterocycles that are 
made up of large cyclic molecules 
containing more than one amine group.  An 
amine is a functional group in organic 
chemistry consisting of a nitrogen atom 




hydrogen or carbon).  (See Figure 2)  When 
an amine group is within a ring, it is bonded 
to two atoms, leaving one site free to bond 
to an atom outside the ring.  Such an amine 
is referred to as a secondary amine.  The 
availability of this secondary amine within 
the ring allows for other atoms, chains, or 
molecules to attach to the ring.  This allows 
macrocyclic polyamines to be designed for 
specific functions depending on what is 
attached to the amine group.(2) 
 
Figure 2: Amine group 
 Recently, interest in macrocyclic 
polyamines has grown tremendously, 
particularly in the medical field.  These 
structures have been studied for a variety of 
uses including magnetic resonance imaging 
(MRI) agents and for their anti-tumor 
activity.  The focus of this study is their anti-
HIV properties.(2) 
 HIV (human immunodeficiency 
virus) is the cause of AIDS (acquired 
immunodeficiency syndrome), the 
transmissible disease of the immune system.  
HIV targets a special class of white blood 
cell called helper T cells, and in doing so, 
weakens the immune system leaving the 
host vulnerable to infections and diseases.  
These secondary infections are what actually 
cause fatalities for those infected with 
HIV.(3) 
 HIV is classified as a retrovirus, 
meaning that it is made up of RNA instead 
of DNA, and therefore, requires a host cell 
in order to replicate.  HIV enters the helper 
T cells via the CD4 receptor, a molecule on 
the cell’s surface.  A protein embedded in 
the membrane of the virus, called gp120, 
binds with the CD4 receptor.  HIV also 
requires the participation of two other 
molecules, CCR5 and CXCR4, which are 
referred to as co-receptors.  They work 
together with the CD4 receptor to allow the 
virus to gain entry into the cell and infect it 
with its genetic material.(3) (See Figure 3) 
 
Figure 3: Depiction of HIV entering cell via 
receptor (CD4) and co-receptors (CCR5 and 
CXCR4)(4) 
Once the virus has infected the cell, 
it converts its RNA into DNA which is then 
integrated into the DNA of the T cell.  At 
this point, the cell is used to create copies of 
the virus’ RNA which is sent out of the cell 
as new viruses ready to infect more T 
cells.(3) 
Most anti-HIV drugs aim to inhibit 
the conversion of its RNA to DNA or they 
target it before it replicates.  These methods, 
however, do not help the cells that have 
already been infected; they can only try and 
prevent the disease from spreading to more 
cells.  Once a cell is infected with HIV, 




ideal anti-HIV drug would, therefore, be one 
that stops the virus before it enters the cell.  
Some types of macrocyclic polyamines have 
been studied for this purpose and were 
found to be successful.  Cyclams, cylens, 
and multilayered macrocyclic polyamines 





Figure 4: Example structures of cyclens, 
cyclams, and multi-layered macrocyclic 
polyamines(2) 
 M40401, a specific macrocyclic 
polyamine, is a known antioxidant.  
Evidence existed in the medical world that 
those infected with HIV-1 were constantly 
under excessive oxidative stress, which 
eventually leads to apoptosis (cell death).  
Studies done on astrocytes (star-shaped cells 
found in the brain) infected with HIV-1 
showed that if the astrocytes were pretreated 
with M40401, apoptosis was greatly 
reduced.  This led to interest in M40401 and 
related compounds being used for their anti-
HIV properties.(5) (See Figure 5) 
 
Figure 5: M40401 
 Sunil Hamal, a graduate student at 
the University of Nevada, Reno, has done a  
significant amount of work on a project to 
synthesize metal complexes of macrocyclic 
polyamines similar to M40401 to be sent 
away for testing against HIV.  Two 
compounds in particular (SH04 and SH06) 
have proven very promising.  It is believed 
they inhibit the entry of HIV-1 into cells by 
binding to one or both of the co-receptors 
(CCR5 and CXCR4).(6),(7) (See Figure 6) 
 
Figure 6: SH04 and SH06 
 This study will focus on synthesizing 
and testing M40403, a molecule very similar 





















molecules to synthesize and test for their 
anti-HIV activity.  (See Figure 7) 
 




      
 




Diagram 1: Retrosynthesis of M40403 
M40403 can be obtained from the 
reduction of the Schiff’s base, which is 
obtained from the metal-templated 
condensation of the head group (prepared by 
Sunil Hamal), ɴ, ɴ’-Bis[(1R,2R)-(2-
amino)cyclohexyl]-1,2-diaminoethane 
tetrachloride, and manganese chloride.  ɴ, 
ɴ’-Bis[(1R,2R)-(2-amino)cyclo-hexyl]-1,2-
diaminoethane tetrachloride is synthesized 




Starting with a racemic mixture of 
trans-1,2-diaminocyclohexane, resolve with 
tartaric acid to yield (1R,2R)-1,2-
diaminocyclohexane L-(+)-tartarate.  Then 
react that with KOH and dry with sodium 
metal. Collect the newly formed (1R,2R)-
1,2-diaminocyclohexane under nitrogen.  
Then mix the free amine with trityl chloride 
to yield ɴ -(triphenylmethyl)-(1R,2R)-1,2-
diaminocyclohexane.  Then mix with 40% 
(W/W) aqueous glyoxal, MeOH, and water 
to yield glyoxal bisimine of ɴ -
(triphenylmethyl)-(1R,2R)-1,2-
diaminocyclohexane.  Reduce the product 
with LiBH4-THF to yield ɴ, ɴ’-Bis[(1R,2R)-
(2-triphenylmethylamino)cyclohexyl]-1,2-
diaminoethane.  (See Diagram 2)  Remove 
the trityl groups by adding acetone and HCl 
to yield ɴ, ɴ’-Bis[(1R,2R)-(2-
amino)cyclohexyl]-1,2-diaminoethane 
tetrachloride.  Perform metal-templated 
condensation with MnCl2 and the head 
group synthesized by Sunil Hamal to yield 
the Schiff’s base.  Then reduce the product 













































hexane: Synthesis of (1R,2R)-1,2-diamino-
cyclohexane L-(+)-tartarate 
 A solution of 48 mL (400 mmol) of 
trans-1,2-diaminocyclohexane, 80 mL of 
water, and 640 mL of methanol (reagent 
grade) was stirred in a 2 L round bottom 
flask.  While still stirring, 60 mL (520 
mmol) glacial acetic acid was added 
dropwise using an addition funnel.  A 
solution of 30.262 g (200 mmol) in 120 mL 
of methanol was added dropwise over a 
period of 2 ½ hours to the stirred solution.  
Then the resulting cloudy reaction mixture 
was refluxed for 24 hours.  The solution was 
taken off heat and let cool overnight.  The 
product was collected by filtration in a 
büchner funnel set up with a 2 L filter flask 
connected to a water aspirator.  The product 
was rinsed three times with 75 mL of 
methanol.  The product was dried via water 
aspirator for 45 minutes and then transferred 
to a tared beaker to dry in an oven at 80˚ C 
for 24 hours.  The product was placed in a 
tared brown product bottle and weighed in at 
50.95 g (192.8 mmol). 
 
Resolution of trans-1,2-diaminocyclo-
hexane: Synthesis of (1S,2S)-1,2-diamino-
cyclohexane dihydrochloride 
 The filtrate from the resolution of 
trans-1,2-diaminocyclohexane the synthesis 
of (1R, 2R)-1,2-diamino-cyclohexane L-(+)-
tartarate was transferred to a three-necked 5 
L round bottom flask.  40 mL (0.5 mol) of 
concentrated hydrochloric acid was added in 
one portion to the filtrate while it was 
stirred.  The solution was heated to reflux 
and 200 mL of reagent grade acetone was 
added dropwise from an addition funnel 
through the top of the condenser to the 





refluxing mixture.  The solution was 
refluxed for 28 hours allowing ample time 
for the acetone to add and mix in 
completely.  The solution was allowed to 
cool to room temperature, and then 
concentrated to a volume of 150-200 mL by 
rotary evaporation.  1.5 L of reagent grade 
acetone was added to the newly 
concentrated solution while stirring, and 
grainy, tan precipitates formed instantly.  
The solution was stirred for 30 minutes and 
then refluxed for 14 hours.  The reaction 
mixture was allowed to cool to room 
temperature and filtered through a büchner 
funnel set up to a 2 L filter flask connected 
to a water aspirator.  The product was 
washed five times with 30 mL of acetone 
and allowed to air dry at room temperature 
for two days.  The product was then 
transferred to a tared brown bottle and 




 14 mL of 25M aqueous potassium 
hydroxide was prepared by dissolving 19.94 
g of potassium hydroxide in 14 mL of water.  
22.96 g (86.9 mmol) of (1R,2R)-1,2-
diaminocyclohexane L-(+)-tartarate was 
swirled with the 14 mL of 25M aqueous 
potassium hydroxide in a 125 mL separatory 
funnel.  Two layers immediately formed; a 
dark organic layer on top and a clear 
aqueous layer with white precipitates on the 
bottom.  The top layer was drawn off 
(approximately 20 mL in volume) using a 
pipette and was transferred to a 250 mL 
round bottom flask.  50 mL of diethyl ether 
(reagent grade) was added to the round 
bottom flask.  To dry the solution, small 
pieces of sodium metal (about ¼ cm³ in 
volume) were added 1-3 at a time, allowing 
time in between for the previously added 
pieces to fully react.  When about thirty 
pieces of sodium metal had been added, the 
solution was no longer reacting much with 
the metal, indicating it was nearly dry.  Ten 
extra pieces were added, and the flask was 
capped with a rubber septum, connected to a 
bubbler, and left overnight.  Then the 
solution was transferred by cannula via 
nitrogen pressure to a 250 mL round bottom 
flask that was flushed with nitrogen and 
contained thirteen small pieces of sodium 
metal.  The solution, which was a dark red 
color, was let stand overnight to ensure 
complete dryness.  The solution was then 
transferred by cannula via nitrogen pressure 
to another 250 mL round bottom flask that 
had been flushed with nitrogen and 
contained some activated charcoal.  The 
flask was allowed to stand for two hours 
being swirled occasionally.  The solution 
was then transferred by cannula via nitrogen 
pressure to a Dannley pressure fritted funnel 
fitted with filter flask.  The solution was 
filtered through celite in the Dannley funnel 
with nitrogen pressure.  The solution was 
then transferred by cannula via nitrogen 
pressure into a 250 mL round bottom flask 
that was flushed with nitrogen.  The solution 
was concentrated using a vacuum pump to a 
volume of approximately 15 mL, at which 
point the solution crystallized.  After 
warming the crystals to room temperature in 
a water bath, they were dissolved.  The 
solution was transferred by cannula via 
nitrogen pressure to a Dannley pressure 




Teflon tape, and parafilm.  It was placed in 
the freezer at -10˚ C for 72 hours.  Peach-
colored needle-shaped crystals formed and 
the filtrate was removed from the funnel 
using nitrogen pressure.  The crystals were 
collected in a tared brown bottle flushed 
with nitrogen.  The crystals weighed 3.00 g 
(26.3 mmol) and they were stored in the 




 A solution of 1.38 g (4.95 mmol) of 
trityl chloride in 10 mL of anhydrous 
dichloromethane (previously distilled over 
anhydrous calcium chloride) was poured 
into an addition funnel.  Then a solution of 
1.16 g (10.2 mmol) of (1R,2R)-1,2-
diaminocyclohexane in 20 mL of anhydrous 
dichloromethane was made and stirred in a 
50 mL round bottom flask under nitrogen at 
0˚ C (via ice bath).  The trityl chloride 
solution was added to the (1R,2R)-1,2-
diaminocyclohexane solution dropwise over 
60 minutes.  Then the reaction mixture was 
allowed to warm to room temperature and 
was stirred for 17.5 hours.  The reaction 
mixture was then heated to 35-40˚ C for 15 
minutes and then allowed to cool back down 
to room temperature.  The solution was 
transferred to a separatory funnel and was 
washed once with 5 mL of water to bring the 
pH of the water wash down to 10.  Then the 
organic bottom layer was separated into an 
Erlenmeyer flask and dried with anhydrous 
sodium sulfate overnight.  The product was 
obtained by gravity filtration and was then 
dried using rotary evaporation.  Once the 
product was dry, it became white and 
foamy.  It was further dried under vacuum 
overnight and collected into a tared product 
bottle.  The product weighed 1.61 g (4.52 
mmol). 
 
Synthesis of glyoxal bisimine of ɴ-
(triphenylmethyl)-(1R,2R)-1,2-diamino-
cyclohexane 
 A solution of 0.92 g (2.6 mmol) of ɴ-
(triphenylmethyl)-(1R,2R)-1,2-diamino-
cyclohexane in 16 mL of methanol was 
stirred in a 50 mL round bottom flask.  0.14 
mL of 40% (W/W) aqueous glyoxal (172 
mg, 1.2 mmol) was added dropwise.  The 
solution was stirred for 26 hours at room 
temperature.  The cloudy off-white reaction 
mixture was vacuum filtered in a büchner 
funnel via water aspirator.  The white 
product was washed with 8 mL of cold 
methanol.  The product was left to dry on 
the vacuum for 20 minutes, placed in a tared 
product vial and further dried under vacuum 
for 24 hours.  The product weighed 0.69 g 
(0.94 mmol). 
 
Synthesis of ɴ, ɴ’-Bis[(1R,2R)-(2-triphenyl-
methylamino)cyclohexyl]-1,2-diamino-
ethane 
 A solution of 0.165 g (0.22 mmol) of 
the glyoxal bisimine of ɴ-(triphenylmethyl)-
(1R,2R)-1,2-diaminocyclohexane in 2 mL of 
freshly distilled tetrahydrofuran (THF) was 
stirred under nitrogen in a 50 mL round 
bottom flask as a solution of 1.5 mL of 2M 
lithium borohydride in THF was added 
dropwise.  The reaction mixture was stirred 




hours at 40˚ C.  Then the reaction mixture 
was cooled to 0˚ C using an ice water bath, 
and 1 mL of cold water was added dropwise 
using a Pasteur pipette.  Most of the THF 
was evaporated using a rotary evaporator 
and the remaining mixture was swirled with 
15 mL of dichloromethane in a separatory 
funnel.  The mixture was gravity filtered 
into an Erlenmeyer flask and the filtrate was 
dried over anhydrous sodium sulfate 
overnight.  It was then filtered, evaporated 
via rotary evaporator, and dried under 
vacuum in a tared round bottom flask.  The 
resulting product was a white foamy solid 




hexane: Synthesis of (1R,2R)-1,2-diamino-
cyclohexane L-(+)-tartarate 
 The experiment was conducted 
twice, the results of which are presented in 
Table 1.  Because the starting material was a 
racemic mixture of both enantiomers, we 
expect there to be about 50% of each one 
present.  Therefore, the yields listed in Table 
1 are very high.   In both cases, the product 
was tan to off-white in color and 
decomposed between 251-259˚ C, which is 
relatively close to the Aldrich literature 
value of 273˚ C. 
Table 1: Results of the synthesis of (1R,2R)-1,2-
diaminocyclohexane L-(+)-tartarate 
Resolution of trans-1,2-diaminocyclo-
hexane: Synthesis of (1S,2S)-1,2-diamino-
cyclohexane dihydrochloride 
 The experiment was performed 
twice, and the results, which can be seen in 
Table 2, were consistently good for both 
trials.  As with the previous experiment, 
50% is the highest percent yield that could 
be expected for this enantiomer, therefore, 
the yields listed in Table 2 are more than 
satisfactory.  The product obtained was a 
tan, powdery solid that decomposed at 301-
304˚ C.  Note that this product was not used 
in any further experiments. 





 The experiment was conducted four 
times, and the results are shown in Table 3.  
The first trial conducted resulted in the 
highest percent yield, however, it took over 
a week to complete because of the many 
stages of drying and transfers between 
flasks.  The end product was very fine 
peach-colored needle-shaped crystals that 
melted at 43˚ C (Aldrich literature melting 
point: 45˚ C). 
In the second trial, an attempt was 
made to cut out a couple steps by 




pressure fritted funnel instead of transferring 
it into a round bottom flask and then 
transferring it back into a Dannley funnel.  
However, while the solution was being 
concentrated via vacuum pump, a leak in the 
Dannley funnel was formed, exposing the 
moisture-sensitive product to the air.  Even 
after re-drying the solution with sodium 
metal and attempting to crystallize the 
product, only a small amount of clumpy 
crystals formed with a melting point of 160˚ 
C.  Clearly, the desired product was not 
obtained. 
In the third trial, the scale was 
doubled, but it was carried out in the same 
way as the first trial, without skipping any 
steps.  The percent yield was a little lower, 
but the crystals were needle-shaped and 
melted at 44˚ C. 
The fourth trial is not complete, and 
the only variation is that the solution was not 
filtered through activated charcoal. 





 The experiment was conducted five 
times, the results of which are shown in 
Table 4.  The first two trials were not 
successful; as Table 4 shows, the first trial 
did not result in any product and the second 
trial resulted in an impure oil.  The oil was 
analyzed via thin layer chromatography 
which showed that it consisted of mainly 
starting material. 
During the third trial, it was 
discovered that a bottle of silica gel was 
mislabeled as sodium sulfate.  Therefore, 
during the previous two trials, while the 
organic layer was thought to be drying over 
sodium sulfate, it was actually being left to 
sit with silica gel.  Because of this, the 
product was being lost after gravity 
filtration.  A new bottle of sodium sulfate 
was obtained and the third trial was 
successful.  The fourth and fifth trials were 
performed similarly and were also 
successful.  In all three trials, the product 
obtained after drying was a white foamy 
solid that melted at 50-60˚ C. 




Synthesis of glyoxal bisimine of ɴ-
(triphenylmethyl)-(1R,2R)-1,2-diamino-
cyclohexane 
 The experiment was conducted three 




This experiment was by far the shortest as it 
only involved stirring the reactants at room 
temperature and then filtration and drying of 
the product.  All three trials were successful 
and had satisfactory percent yields.  The 
product collected was a white solid that 
melted at 204-214˚ C. 




Synthesis of ɴ, ɴ’-Bis[(1R,2R)-(2-triphenyl-
methylamino)cyclohexyl]-1,2-diamino-
ethane 
 The experiment was only performed 
once and on a small scale.  The results can 
be seen in Table 6.  Note that there is not 
enough product to continue on with the 
experiments at this time. 





 The first six experiments that have 
been conducted have all yielded successful 
results.  However, at this time there is not 
enough ɴ, ɴ’-Bis[(1R,2R)-(2-triphenyl-
methylamino)cyclohexyl]-1,2-diamino-
ethane to continue on to the synthesis of ɴ, 
ɴ’-Bis[(1R,2R)-(2-amino)cyclohexyl]-1,2-
diaminoethane.  Currently the synthesis of 
(1R,2R)-1,2-diaminocyclohexane is being 
repeated so that there is enough product to 
conduct the next three experiments with to 
result in at least 1 gram of ɴ, ɴ’-
Bis[(1R,2R)-(2-triphenylmethylamino)-
cyclohexyl]-1,2-diaminoethane.  Once that 
is achieved, the experiments can continue on 
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